

Key Features & Benefits:
- Provides up to 6 months efficacy with only 3 injections
- Same trusted formulation as Orthovisc
- 1 mL volume provides appropriate dosage for small joints
- High molecular weight, high concentration, and high viscosity formulation
- Natural, non-animal sourced HA
Orthovisc mini is not approved for use in the United States.
In the European Economic Area and other parts of the world, Orthovisc mini is indicated as a viscoelastic supplement or a replacement for synovial fluid in human joints. Orthovisc mini is well suited for treatment of the symptoms of human synovial joint dysfunctions such as osteoarthritis. The actions of Orthovisc mini are lubrication and mechanical support.
Anika products may not be available in all geographies. Product availability is subject to the regulatory clearances in individual markets. Please reach out to your local representative or Contact Us if you have questions about specific market approvals.
View More Products
Orthovisc
Multi-injection hyaluronic acid (HA) viscosupplement
Monovisc
Single-injection hyaluronic acid (HA) viscosupplement
Cingal
Single-injection combination hyaluronic acid (HA) plus steroid treatment for osteoarthritis pain (not approved in the U.S.)